Lab resourceCo-expression of tissue factor and IL-6 in immature endothelial cells of cerebral cavernous malformations

- The expression of tissue factor (TF) and interleukin-6 (IL-6) in cerebral cavernous malformations (CCMs) was analyzed.
- The mRNA expression of TF of CCMs was significantly higher than that of the control.
- The mRNA expression of TF was correlated with the number of hemorrhage appearances and the mRNA expression level of IL-6.
- TF and both are present in the same immature endothelial cells.
- These factors may have a prognostic role in CCM.

Cerebral cavernous malformations (CCMs) are congenital abnormal clusters of capillaries that are prone to leaking and thought to result from a disorder of endothelial cells. The underlying pathology of CCM is not fully understood. We analyzed the expression of tissue factor (TF) and interleukin-6 (IL-6) in CCMs to determine the association of TF and IL-6 with clinical and pathological findings. Thirteen cases of operative specimens of sporadic CCMs were included in this study. The expression of messenger RNA of TF and IL-6 was assayed and the association with clinical factors was investigated. Then, the distribution of TF and IL-6 was examined with immunofluorescence. The mRNA expression of TF of CCMs was significantly higher than that of the control (p = 0.017), and was correlated with the number of hemorrhage appearances (p = 0.190, ρ = 0.62). The mRNA expression level of IL-6 was significantly correlated with the mRNA expression level of TF (p = 0.034, ρ = 0.58). Examination of immunostained sections indicated that TF+ cells were also positive for IL-6, and distributed around normal endothelial cells. Moreover, the TF+/IL-6+ cells expressed CD31 and VEGFR2. The expressions of IL-6 and TF were correlated, and both were present in the same immature endothelial cells. TF is elevated in CCM and might mediate progressive events. These factors may play a prognostic role in CCM.